NEW DELHI,JAN 17: The Drug Controller General of India (DCGI) has approved market authorisation to COVID-19 vaccine Covovax as a heterologous booster dose for adults who have been administered two doses of Covishield or Covaxin, official sources said on Monday. The DCGI’s approval came following recommendation by the Subject Expert Committee of the Central Drugs […]Continue Reading
